Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Derks, Michael
269  Ergebnisse:
Personensuche X
?
1

A population pharmacokinetics model of balovaptan to suppor..:

Schaedeli Stark, Franziska ; Chavanne, Clarisse ; Derks, Michael...
Journal of Pharmacokinetics and Pharmacodynamics.  51 (2024)  3 - p. 227-242 , 2024
Link: https://doi.org/10.1007/..
 
?
2

A randomized, double-blind, placebo-controlled phase II tri..:

Goeldner, Celia ; Kishnani, Priya S. ; Skotko, Brian G....
Journal of Neurodevelopmental Disorders.  14 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
3

Basmisanil, a highly selective GABAA-α5 negative allosteric..:

Hipp, Joerg F. ; Knoflach, Frederic ; Comley, Robert...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
4

PKPD and cardiac single cell modeling of a DDI study with a..:

Jaminion, Felix ; Bentley, Darren ; Wang, Ken...
Journal of Pharmacokinetics and Pharmacodynamics.  47 (2020)  5 - p. 447-459 , 2020
Link: https://doi.org/10.1007/..
 
?
5

Population Pharmacokinetic and Exposure–dizziness Modeling ..:

Cosson, Valérie ; Schaedeli‐Stark, Franziska ; Arab‐Alameddine, Mona...
Clinical and Translational Science.  11 (2018)  5 - p. 523-531 , 2018
Link: https://doi.org/10.1111/..
 
?
6

Results and evaluation of a first-in-human study of RG7342,..:

Sturm, Stefan ; Delporte, Marie-Laure ; Hadi, Salah...
British Journal of Clinical Pharmacology.  84 (2017)  3 - p. 445-455 , 2017
Link: https://doi.org/10.1111/..
 
?
7

Clinical Pharmacology Knowledge, Opportunities and Working ..:

Nieforth, Keith A. ; Abdallah, Hisham Y. ; Smith, Patrick...
British Journal of Clinical Pharmacology.  76 (2013)  6 - p. 841-845 , 2013
Link: https://doi.org/10.1111/..
 
?
8

No clinically relevant drug–drug interactions when dalcetra..:

Young, Annie ; Anzures-Cabrera, Judith ; Derks, Michael
Int. Journal of Clinical Pharmacology and Therapeutics.  50 (2012)  4 - p. 248-256 , 2012
Link: https://doi.org/10.5414/..
 
?
9

Effect of dalcetrapib on non-cholesterol markers of cholest..:

Niesor, Eric J. ; Chaput, Evelyne ; Staempfli, Andreas...
Atherosclerosis.  218 (2011)  2 - p. e8 , 2011
Link: https://doi.org/10.1016/..
 
?
10

Effects of Food Intake on the Pharmacokinetic Properties of..:

Derks, Michael ; Kawamura, Hitoshi ; Abt, Markus...
Clinical Therapeutics.  33 (2011)  6 - p. 754-765 , 2011
Link: https://doi.org/10.1016/..
 
?
11

Effect of dalcetrapib, a CETP modulator, on non-cholesterol..:

Niesor, Eric J. ; Chaput, Evelyne ; Staempfli, Andreas...
Atherosclerosis.  219 (2011)  2 - p. 761-767 , 2011
Link: https://doi.org/10.1016/..
 
?
12

Safety, Tolerability and Pharmacokinetics of Dalcetrapib Fo..:

Derks, Michael ; Anzures-Cabrera, Judith ; Turnbull, Lynn.
Clinical Drug Investigation.  31 (2011)  5 - p. 325-335 , 2011
Link: https://doi.org/10.1007/..
 
?
13

Safety, Tolerability and Pharmacokinetics of Dalcetrapib Fo..:

Derks, Michael ; Anzures-Cabrera, Judith ; Turnbull, Lynn.
Clinical Drug Investigation.  , 2011
Link: https://doi.org/10.2165/..
 
?
14

Coadministration of Dalcetrapib With Pravastatin, Rosuvasta..:

Derks, Michael ; Abt, Markus ; Phelan, Mary...
The Journal of Clinical Pharmacology.  50 (2010)  10 - p. 1188-1201 , 2010
Link: https://doi.org/10.1177/..
 
?
15

Lack of clinically relevant drug–drug interactions when dal..:

Derks, Michael ; Abt, Markus ; Phelan, Mary
British Journal of Clinical Pharmacology.  70 (2010)  6 - p. 825-833 , 2010
Link: https://doi.org/10.1111/..
 
1-15